title: High-dose folic acid supplements and responsiveness to rHu-EPO in HD patients.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Sepe
authors.forename: Gabriella
authors.initials: G
authors.lastname: Adamo
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Giuliano
authors.forename: Grazia
authors.initials: G
authors.lastname: Soccio
authors.forename: Carmelo
authors.initials: C
authors.lastname: Libetta
authors.forename: Antonio
authors.initials: A
authors.lastname: Dal Canton
mesh_terms: D000368:Aged; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D005494:Folic Acid Deficiency / Q000150:complications / Q000628:therapy*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D005492:Folic Acid